Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 May 2023 | Story Leonie Bolleurs | Photo Supplied
Eco-vehicle Race
Join the UFS on 13 May 2023 at 09:00 (student performances at 09:00 and race at 10:15) on the road around the UFS Odeion School of Music for the annual Kovsie ACT Eco-Vehicle Race. Don't miss out on this incredible display of endurance; support your favourite team to victory!

Kovsie ACT at the University of the Free State (UFS) is presenting the sixth Kovsie Eco-Vehicle Race this year.

Come and show your support for our students who will be representing our colleges and three campuses, along with the Central University of Technology. Be a part of the action:

Date: Saturday 13 May 2023
Time: 09:00 Performances by student artists
Time: 10:15 Official start of Eco-Vehicle Race
Venue: UFS Odeion School of Music parking area

The Eco-Vehicle Race represents the last phase of a nine-month co-curricular skills programme, providing our students with a set of skills that prepare them for the world of work. 

In this programme where students are equipped with basic knowledge and skills on sustainable energy, they get the opportunity not only to race the eco-vehicles, but to also understand the workings of the vehicle, which is critical for repairs done by the team during the race. 

Our students will be competing in three events:

  • Obstacle course: Teams will be challenged by obstacles to test their control over the car.
  • Smart lap: A timed lap in which the drivers take the main track for the first time.
  • Endurance race: The teams need to finish as many laps as possible using the least amount of energy in 45 minutes. 
The winners of the three events will each receive a trophy. There will be a trophy for the best pit stop as well as a spirit cup for the team with the best energy and support from the audience.

Come and support our students as they showcase their ingenuity and endurance. Don't miss out on the action! For more information, click here to contact Jady Carelse.

Car manufacturers will also exhibit hybrid/electric vehicles; come and view the exhibition and learn more about how these cars work and their benefits.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept